Nano Holdings, Inc. (4571.T)
Tokyo · JPY · Healthcare · Biotechnology
¥79 (+2.60%) as of
Key statistics
- Market cap
- 6.61B
- Forward P/E
- -3.25
- EPS (TTM)
- -13.44
- Dividend yield
- 0.00%
- 52-week range
- 72.00 – 195.00
- Beta
- 0.41
- Revenue (TTM)
- 202M
- Profit margin
- 0.00%
- Volume
- 399.30k
About Nano Holdings, Inc.
Nano Holdings, Inc. researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan. The company's pipeline products include RUNX1 (mRNA) for the treatment knee osteoarthritis and reduces pain. Its product pipeline also comprises TUG1 (ASO) for glioblastoma multiforme. In addition, it offers cosmetic raw material. The company was formerly known as NANO MRNA Co.,Ltd. and changed its name to Nano Holdings, Inc. in December 2025. Nano Holdings, Inc. was incorporated in 1996 and is headquartered in Minato, Japan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Minato, Japan
- Employees
- 23
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.